Skip to content

R&D at other companies

Schrodinger logo
SchrodingerSDGR
$43.82M-4.4%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$87.9M-32.2%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$60.41M+45.1%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$46.66M+9.8%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$33.99M-17.5%
ADMA Biologics logo
ADMA BiologicsADMA
$2.6M+214%

Segments

By product

See full
Drug creation program and platform$6.08M+52.4%
External preclinical and clinical development$4.29M+59.7%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's R&D?
Absci Corporation (ABSI) reported R&D of $19.28M in Q1 2026.
How has Absci Corporation's R&D changed year-over-year?
Absci Corporation's R&D increased by 17.8% year-over-year, from $16.36M to $19.28M.
What is the long-term trend for Absci Corporation's R&D?
Over 4 years (2021 to 2025), Absci Corporation's R&D has grown at a 16.2% compound annual growth rate (CAGR), from $44.59M to $81.42M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.